C12Y 301/01077
Acyloxyacyl hydrolase
Official title: Acyloxyacyl hydrolase (3.1.1.77)
C12Y301/01077 (Acyloxyacyl hydrolase) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 3
- Assignees
- 4
- Inventors
- 15
- Latest grant
- 24 Nov 1998
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Immunogenic engineered live-attenuated gram-negative pathogen vaccines having reduced endotoxicity18 Jun 2026US 2026/0167923 A1The Government of The United States, as represented by the Defense Health Agency
- Live salmonella typhi vectors engineered to express cancer protein antigens and methods of use thereof7 Sep 2023US 2023/0277642 A1Irazu Bio
- Genetically-engineered mesenchymal stem cells overexpressing aoah and uses thereof13 Jan 2022US 2022/0010281 A1
Most cited
By later US patents